#emapresser — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #emapresser, aggregated by home.social.
-
If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines.
The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080058241581057
-
If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines.
The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080058241581057
-
If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines.
The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080058241581057
-
We placed extra obligations on the #Covid19vaccine makers.
They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079498784366597
-
We placed extra obligations on the #Covid19vaccine makers.
They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079498784366597
-
We placed extra obligations on the #Covid19vaccine makers.
They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079498784366597
-
#RealWorldData on the #Mpox vaccine show that it is effective, especially after 2⃣ doses.
Discussions are ongoing with developers of other vaccines for Mpox and other viruses of the same type.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1625845803758518273
-
This autumn, EMA became the 1st regulator in the 🌍 to approve #Beyfortus, a monoclonal antibody to prevent serious lower respiratory tract disease caused by #RSV in newborns & children. #EMAPresser
🐦🔗: https://n.respublicae.eu/EMA_News/status/1603694029446725635